AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2017
Apr 4, 2017
33483_dirs_2017-04-04_35b66c1a-f504-43f8-b723-e63f44ee50f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-03-27
Reporting Person: BARABE TIMOTHY C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-27 | Common Stock | M | 2492 | $11.00 | Acquired | 2492 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-27 | Stock Option (Right to Buy) | $11.00 | M | 2492 | Disposed | 2026-07-28 | Common Stock (2492) | Direct |
Footnotes
F1: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8